The mRNA level of glutamine‐fructose‐6‐phosphate transaminase 2 (GFPT2) is upregulated in many cancers, such as glioblastoma, lung adenocarcinoma and breast cancer [39, 40]. This evidence concerns the gene GFPT2 and breast carcinoma.